throbber
Paper No. __
`Filed: September 17, 2015
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`WOCKHARDT BIO AG
`Petitioner,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.
`Patent Owner
`
`________________
`
`Case IPR2015-01818
`Patent 7,668,730
`
`________________
`
`
`
`MANDATORY NOTICES BY JAZZ PHARMACEUTICALS, INC.
`UNDER 35 U.S.C. §§ 311-319 AND 37 C.F.R. §§ 42.8, 42.100 ET. SEQ.
`
`03387-00001/7207376.1
`
`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2015-01818
` Patent 7,668,730
`
`
`Patent Owner Mandatory Notices
`
`
`REAL PARTY-IN-INTEREST
`
`Pursuant to the requirements of 37 C.F.R. § 42.8(b)(1), the undersigned state
`
`that Jazz Pharmaceuticals, Inc. (“Jazz Pharmaceuticals”) is the real party-in-
`
`interest. Jazz Pharmaceuticals is a corporation organized and existing under the
`
`laws of the State of Delaware, having a principal place of business at 3180 Porter
`
`Drive, Palo Alto, California 94304. Jazz Pharmaceuticals owns by assignment the
`
`entire right, title, and interest in U.S. Patent No. 7,668,730 (the “’730 patent”) by
`
`virtue of an Assignment of rights from the inventors, Dayton Reardon, Patti Engle
`
`and Bob Gagne. The Assignment was recorded with the United States Patent and
`
`Trademark Office on December 22, 2010, at Reel 025604, Frame 0903.
`
`RELATED MATTERS
`
`Pursuant to 37 C.F.R. § 42.8(b)(2), the undersigned state that the ’730 patent
`
`is the subject of four, currently-pending litigations: Jazz Pharmaceuticals, Inc. v.
`
`Roxane Laboratories, Inc., 2:10-cv-6108 (D.N.J.); Jazz Pharmaceuticals, Inc. v.
`
`Amneal Pharmaceuticals LLC et al., 2:13-cv-391 (consolidated) (D.N.J.); Jazz
`
`Pharmaceuticals, Inc. v. Wockhardt Bio AG et al., 2:15-cv-5619 (D.N.J.); and Jazz
`
`Pharmaceuticals, Inc. v. Lupin Ltd. et al., 2:15-cv-6548 (D.N.J.). The litigation
`
`over the ’730 patent in Jazz Pharms., Inc. v. Roxane Labs., Inc. was stayed prior to
`
`Petitioner filing the present IPR Petition.
`
`03387-00001/7207376.1
`
`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2015-01818
` Patent 7,668,730
`
`
`Patent Owner Mandatory Notices
`
`
`The ’730 patent is also the subject of an inter partes review petition filed by
`
`Par Pharmaceutical, Inc. (“Par”) and Amneal Pharmaceuticals LLC (“Amneal”)
`
`(IPR2015-00554). Additionally, Petitioner has filed for inter partes review of five
`
`related patents: U.S. Patent No. 8,457,988 (IPR2015-01814); U.S. Patent No.
`
`7,895,059 (IPR2015-01816); U.S. Patent No. 8,589,182 (IPR2015-01813); U.S.
`
`Patent No. 7,765,106 (IPR2015-01815); and U.S. Patent No. 7,765,107 (IPR2015-
`
`01820).
`
`Further, Par and Amneal have together (and in certain instances, separately)
`
`filed for inter partes review of the above-identified related patents: U.S. Patent
`
`No. 8,457,988 (IPR2015-00551; IPR2015-01817); U.S. Patent No. 7,895,059
`
`(IPR2015-00548; IPR2015-01810); U.S. Patent No. 8,589,182 (IPR2015-00545);
`
`U.S. Patent No. 7,765,106 (IPR2015-00546); and U.S. Patent No. 7,765,107
`
`(IPR2015-00547). The Coalition for Affordable Drugs III LLC has also filed a
`
`petition for inter partes review of related U.S. Patent No. 7,895,059 (IPR2015-
`
`01018).
`
`Par and Amneal have also previously filed for covered business method
`
`review of the ’730 patent (CBM2014-00151) and the above-identified related
`
`patents: U.S. Patent No. 8,457,988 (CBM2014-00150); U.S. Patent No. 7,895,059
`
`(CBM2014-00149); U.S. Patent No. 8,589,182 (CBM2014-00153); U.S. Patent
`
`03387-00001/7207376.1
`
`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2015-01818
` Patent 7,668,730
`
`
`Patent Owner Mandatory Notices
`
`
`No. 7,765,106 (CBM2014-00161); and U.S. Patent No. 7,765,107 (CBM2014-
`
`00175). On January 13, 2015, the Patent Trial and Appeal Board (the “Board”)
`
`denied institution of covered business method review of the ’730 patent in
`
`CBM2014-00151, as well as the patents involved in CBM2014-00149, CBM2014-
`
`00150 and CBM2014-00153. See CBM2014-00149 at Paper 12. On February 9,
`
`2015, the Board denied institution of covered business method review of the
`
`patents involved in CBM2014-00161 and CBM2014-00175. See CBM2014-00175
`
`at Paper 14.
`
`Further, the following pending U.S. Patent applications claim the benefit of
`
`the ’730 patent: U.S. Patent Application No. 14/196,603, filed on March 4, 2014,
`
`U.S. Patent Application No. 14/219,904, filed on March 19, 2014, and U.S. Patent
`
`Application No. 14/219,941 filed on March 19, 2014.
`
`LEAD COUNSEL AND BACK-UP COUNSEL (37 C.F.R. § 42.8(b)(3))
`
`Lead Counsel:
`
`
`
`F. Dominic Cerrito (Reg. No. 38,100)
`
`Contact Information:
`
`Quinn Emanuel Urquhart & Sullivan, LLP
`
`51 Madison Avenue, 22nd Floor
`
`New York, NY 10010
`
`Email: nickcerrito@quinnemanuel.com
`
`Telephone: 212-849-7000
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`03387-00001/7207376.1
`
`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2015-01818
` Patent 7,668,730
`
`
`Patent Owner Mandatory Notices
`
`
`Back-Up Counsel:
`
`John V. Biernacki (Reg. No. 40,511)
`
`Contact Information:
`
`Jones Day
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`North Point
`
`901 Lakeside Avenue
`
`Cleveland, OH 44114
`
`Email: jvbiernacki@jonesday.com
`
`Telephone: 216-586-3939
`
`Back-Up Counsel:
`
`Evangeline Shih (Reg. No. 50,170)
`
`Contact Information:
`
`Quinn Emanuel Urquhart & Sullivan, LLP
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`51 Madison Avenue, 22nd Floor
`
`New York, NY 10010
`
`Email: evangelineshih@quinnemanuel.com
`
`Telephone: 212-849-7000
`
`Back-Up Counsel:
`
`Frank C. Calvosa (Reg. No. 69,064)
`
`Contact Information:
`
`Quinn Emanuel Urquhart & Sullivan, LLP
`
`51 Madison Avenue, 22nd Floor
`
`New York, NY 10010
`
`Email: frankcalvosa@quinnemanuel.com
`
`Telephone: 212-849-7000
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`03387-00001/7207376.1
`
`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2015-01818
` Patent 7,668,730
`
`
`Patent Owner Mandatory Notices
`
`
`SERVICE INFORMATION
`
`Pursuant to 37 C.F.R. § 42.8(b)(4), please direct all correspondence to lead
`
`and back-up counsel at the above addresses. Patent Owner consents to email
`
`service at the above-specified email addresses.
`
`Date: September 17, 2015
`
`
`Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito (Reg. No. 38,100)
` Evangeline Shih (Reg. No. 50,170)
` Frank C. Calvosa (Reg. No. 69,064)
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`evangelineshish@quinnemanuel.com
`frankcalvosa@quinnemanuel.com
`John V. Biernacki (Reg. No. 40,511)
`JONES DAY
`North Point
`901 Lakeside Avenue
`Cleveland, Ohio 44114
`Tel: (216) 586-3939
`Fax: (216) 579-0212
`jvbiernacki@jonesday.com
`
`Attorneys for Jazz Pharmaceuticals, Inc.
`
`
`
`
`
`03387-00001/7207376.1
`
`

`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`WOCKHARDT BIO AG
`Petitioner,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.
`Patent Owner
`
`________________
`
`Case IPR2015-01818
`Patent 7,668,730
`________________
`
`CERTIFICATE OF SERVICE
`
`
`
`
`
`03387-00001/7207376.1
`
`

`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned hereby certify that
`
`MANDATORY NOTICES BY JAZZ PHARMACEUTICALS, INC. and the
`
`attached POWER OF ATTORNEY and 3.73(b) STATEMENT were served on
`
`September 17, 2015 by filing these documents through the Patent Review
`
`Processing System, as well as e-mailing copies to lavogel@duanemorris.com and
`
`PCGallagher@duanemorris.com.
`
`Date: September 17, 2015
`
`03387-00001/7207376.1
`
` Respectfully submitted,
`
`By: /F. Dominic Cerrito (Reg. No. 38,100)/
` F. Dominic Cerrito (Reg. No. 38,100)
` Evangeline Shih (Reg. No. 50,170)
` Frank C. Calvosa (Reg. No. 69,064)
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`evangelineshish@quinnemanuel.com
`frankcalvosa@quinnemanuel.com
`
`John V. Biernacki (Reg. No. 40,511)
`JONES DAY
`North Point
`901 Lakeside Avenue
`Cleveland, Ohio 44114
`Tel: (216) 586-3939
`Fax: (216) 579-0212
`jvbiernacki@jonesday.com
`
`Attorneys for Jazz Pharmaceuticals, Inc.

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket